Voglow M 500mg/0.2mg Tablet
By Voglow M
Rx
10 Tablet in a Strip

Composition
Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Primus Remedies Pvt Ltd
Primus Remedies Pvt Ltd, C-16, Ankur Cooperative Society, Thakurli Estate, Dombivili, Mumbai-421202.

Expires on or after
February, 2027
About Voglow M 500mg/0.2mg Tablet
Voglow M 500mg/0.2mg Tablet is a medication classified as an anti-diabetic drug. It is a combination of medicines specifically designed to manage type 2 diabetes mellitus in adults. This medication works by helping to regulate blood sugar levels in individuals with diabetes. It is essential to take Voglow M 500mg/0.2mg Tablet with food consistently at the same time each day to achieve the maximum benefits. Your doctor will determine the appropriate dosage for you, which may vary depending on how well it is controlling your blood sugar levels.
Continuing to take Voglow M 500mg/0.2mg Tablet as prescribed is crucial, even if you are feeling well or if your blood sugar levels are stable. Abruptly stopping the medication without consulting your doctor can result in elevated blood sugar levels, putting you at risk of complications such as kidney damage, blindness, nerve issues, and limb loss. Remember, Voglow M 500mg/0.2mg Tablet should complement a comprehensive treatment regimen that includes a balanced diet, regular physical activity, and weight management as advised by your healthcare provider.
While Voglow M 500mg/0.2mg Tablet is generally well-tolerated, some individuals may experience temporary side effects such as nausea, changes in taste, loss of appetite, flatulence, stomach discomfort, diarrhea, and skin rash. These side effects typically diminish on their own. If they persist or concern you, it is essential to consult your doctor for guidance on managing or addressing them effectively. It is important to note that Voglow M 500mg/0.2mg Tablet is not suitable for individuals with type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney or liver disease. Inform your doctor about any history of heart disease before starting this medication.
Before incorporating Voglow M 500mg/0.2mg Tablet into your treatment plan, pregnant or breastfeeding women should seek medical advice. Regular monitoring of blood sugar levels, as well as periodic blood tests to check blood cell counts and liver function, may be recommended by your doctor while using this medication. Maintaining a healthy lifestyle is fundamental in managing diabetes effectively and ensuring the best possible outcomes.
Benefits
Voglow M 500mg/0.2mg Tablet is a medication that plays a crucial role in managing Type 2 diabetes mellitus. By controlling high blood glucose levels, this tablet helps to slow down the breakdown of food in the intestine into simple glucose, thus preventing a rapid increase in blood sugar levels after meals. Furthermore, it aids in eliminating excess glucose from the body through urine. Maintaining lower blood glucose levels is vital for managing diabetes effectively and reducing the risk of developing serious complications such as kidney damage, eye damage, nerve problems, and limb amputation. For individuals with type 2 diabetes and existing cardiovascular disease, Voglow M 500mg/0.2mg Tablet also lowers the risk of mortality due to cardiovascular issues. By consistently taking this medicine in combination with a healthy diet and regular exercise, individuals can lead a normal and healthy life. It is essential to adhere to the prescribed regimen to safeguard future health and overall well-being.
How to use the Voglow M 500mg/0.2mg Tablet
To use Voglow M 500mg/0.2mg Tablet, follow the instructions provided by your doctor. Take the medicine in the dosage and for the duration recommended by your doctor. Swallow the tablet whole with a meal; do not chew, crush, or break it. Taking this tablet with food helps with proper absorption and reduces the risk of stomach upset. Remember to take Voglow M 500mg/0.2mg Tablet as directed for best results. If you have any questions or concerns about how to use this medication, consult your healthcare provider for guidance.
Uses of Voglow M 500mg/0.2mg Tablet
The Voglow M 500mg/0.2mg Tablet is primarily used for the treatment of Type 2 diabetes mellitus. It is specifically designed to help manage and control the blood sugar levels in individuals diagnosed with this condition. The tablet works by regulating the body's insulin levels and improving the way the body uses glucose. By using the Voglow M 500mg/0.2mg Tablet as prescribed, individuals with Type 2 diabetes mellitus can effectively control their blood sugar levels, reducing the risk of complications associated with uncontrolled diabetes. It is important to follow the healthcare provider's instructions on the dosage and frequency of the Voglow M 500mg/0.2mg Tablet to achieve optimal results in managing Type 2 diabetes mellitus.
What conditions Voglow M 500mg/0.2mg Tablet treats?
Voglow M 500mg/0.2mg Tablet is used in the treatment of Type 2 diabetes mellitus. It helps in controlling high blood sugar levels by slowing down the breakdown of food into glucose in the intestine. By reducing the rise in blood sugar levels after meals and eliminating excess glucose through urine, it plays a vital role in managing diabetes. This medication is essential to prevent serious complications such as kidney damage, eye issues, nerve problems, and limb loss. Regular intake, in combination with a healthy diet and exercise, supports a healthy life by reducing cardiovascular disease risks.
Should you consult a doctor?
If you experience persistent side effects such as flatulence, diarrhea, abdominal pain, vomiting, or decreased appetite while taking Voglow M 500mg/0.2mg Tablet, it is advisable to consult your doctor. Additionally, seek medical advice if these symptoms worsen or if you have concerns about them. Remember, this medication is an essential part of managing type 2 diabetes, and stopping it without consulting your doctor could lead to a dangerous rise in blood sugar levels, putting you at risk of complications like kidney damage, blindness, nerve issues, and limb loss. Always keep track of your symptoms and communicate any changes or discomfort to your healthcare provider promptly for appropriate guidance and support in managing your condition effectively.
Side effects of Voglow M 500mg/0.2mg Tablet
When taking Voglow M 500mg/0.2mg Tablet, there are some common side effects you may experience. Many of these side effects are temporary and may go away as your body gets used to the medication. However, if these effects persist or become concerning to you, it's important to consult your doctor. Possible side effects of Voglow M 500mg/0.2mg Tablet include flatulence, diarrhea, abdominal pain, vomiting, and decreased appetite. These effects can vary in intensity from person to person.
Safety advice

liver
For individuals with liver disease, there is limited information regarding the use of Voglow M 500mg/0.2mg Tablet. It is recommended to consult a healthcare professional before taking this medication to ensure safety and effectiveness.

kidney
Caution Voglow M 500mg/0.2mg Tablet requires caution in kidney disease patients. Dose adjustment may be necessary and avoid in severe cases. Monitor kidney function regularly while on this medication.

alcohol
It is advised not to drink alcohol while taking Voglow M 500mg/0.2mg Tablet to avoid potential risks.

driving
When taking Voglow M 500mg/0.2mg Tablet, it is important to be aware of the risk of hypoglycemia when using it along with other antidiabetic medications. This could affect driving ability, so remain cautious when driving.

pregnancy
Voglow M 500mg/0.2mg Tablet may not be safe to use during pregnancy as animal studies have shown harm to the developing baby. Consult your doctor for advice.

breastfeeding
Caution must be taken when breastfeeding while using Voglow M 500mg/0.2mg Tablet as it may be unsafe. Limited human data indicates potential harm to the baby through transmission of the drug via breastmilk.
Consumption warning before consuming Voglow M 500mg/0.2mg Tablet
Before consuming Voglow M 500mg/0.2mg Tablet, it is important to keep in mind several key points. This medicine is categorized as an anti-diabetic drug specifically designed to manage type 2 diabetes mellitus in adults by regulating blood sugar levels. It should always be taken with food, consistently at the same time each day as determined by your doctor. Even if you are feeling well or your blood sugar seems controlled, it is crucial to continue taking the medication as prescribed. Abruptly stopping it without medical advice can lead to a dangerous increase in blood sugar levels, possibly resulting in complications such as kidney damage, vision problems, nerve issues, and even limb amputation. Remember, Voglow M 500mg/0.2mg Tablet is just one aspect of a comprehensive treatment plan which should also include a balanced diet, regular exercise, and weight management as guided by your healthcare provider. While temporary side effects like nausea, changes in taste, or stomach discomfort may occur, consulting your doctor is recommended if these persist or concern you. It is imperative to disclose any history of certain health conditions, such as heart disease, to your doctor before initiating this medication. Pregnant or breastfeeding individuals should also seek medical advice before using this tablet. Regular monitoring of blood sugar levels and potential blood tests to assess organ function may be advised as part of the treatment regimen.
What if you forgot to take Voglow M 500mg/0.2mg Tablet?
If you forget to take your Voglow M 500mg/0.2mg Tablet, try to take it as soon as you remember. But if it's close to the time for your next dose, just skip the missed one and continue with your regular dosing schedule. It's important not to take a double dose to make up for the missed one. This will help maintain the right level of the medication in your body. If you have any concerns about missed doses or if you frequently forget to take your medication, it might be helpful to set reminders or talk to your healthcare provider for advice. Remember, consistency with your medication routine is key for its effectiveness.
Related lab tests
For monitoring the effects of 'Voglow M 500mg/0.2mg Tablet' on blood sugar levels, related lab tests include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin. The Glucose - Fasting Blood test measures the sugar levels in the blood after a period of fasting, providing information on how the body processes glucose without the influence of recent food intake. The Glucose - Postprandial Blood test, on the other hand, measures the blood sugar levels after a meal, offering insights into how the body responds to food. Lastly, the Glycosylated Hemoglobin test gives an overview of the average blood sugar levels over the past few months, providing a more long-term view of glucose control. These tests help healthcare providers assess the impact of 'Voglow M 500mg/0.2mg Tablet' on blood sugar levels and adjust treatment plans accordingly.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹98.2
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024